This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Daniel Ahlstedt
Chief Operating Officer and Co-Founder at EnPlusOne Bio
Speaker

Profile

Dan is Co-founder and COO of EnPlusOne. He joined the founding team in business school through Harvard’s Activate Program, drawn to the potential of EnPlusOne’s enzymatic RNA synthesis platform. As a Blavatnik Fellow, he gained key resources and mentorship to help launch the company in 2022. Since then, EnPlusOne has raised $22M to advance its technology. Previously, Dan was a process engineer at Sanofi, supporting large-scale cGMP manufacturing and leading purification operations for an award-winning biomanufacturing facility. He holds a BS in Chemical Engineering from Northeastern University and an MBA from Harvard Business School.

Agenda Sessions

  • Solving the Scale Problem: Template-independent Enzymatic Synthesis of siRNA Oligonucleotides

    10:45am